EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma

Michael Schieber, Shuo Ma

Blood and Lymphatic Cancer: Targets and Therapy · 2019

DOI: 10.2147/blctt.s177009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2019. Verfasst von Michael Schieber und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern Unive…. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

BCL2CLLSLLvenetoclax

Autor:innen und Institutionen

  • Department of Medicine, Division of Hematology/Oncology, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.

Zitieren

APA

Schieber, M., & Ma, S. (2019). The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma. Blood and Lymphatic Cancer: Targets and Therapy. https://doi.org/10.2147/blctt.s177009

Vancouver

Schieber M, Ma S. The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma. Blood and Lymphatic Cancer: Targets and Therapy. 2019. doi:10.2147/blctt.s177009

BibTeX
@article{Schieber2019,
  author = {Schieber, Michael and Ma, Shuo},
  title = {The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma},
  journal = {Blood and Lymphatic Cancer: Targets and Therapy},
  year = {2019},
  doi = {10.2147/blctt.s177009}
}
Kostenlos starten →